Clinical Outcomes of Melanoma Brain Metastases Treated with Stereotactic Radiosurgery and Anti-PD-1 Therapy, Anti-CTLA-4 Therapy, BRAF/MEK Inhibitors, BRAF Inhibitor, or Conventional Chemotherapy
Ahmed, K.A., Abuodeh, Y.A., Echevarria, M.I., Arrington, J.A., Stallworth, D.G., Hogue, C., Naghavi, A.O., Kim, S., Kim, Y., Patel, B.G., Sarangkasiri, S., Johnstone, P.A.S., Sahebjam, S., Khushalani,Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw417
Date:
September, 2016
File:
PDF, 926 KB
english, 2016
File converter
More search results
More benefits 
